PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.3300
-0.0050 (-1.49%)
At close: Feb 13, 2026
PuraPharm Corporation Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -38.56 | -35.44 | -106.08 | -120.21 | -121.88 | 31.71 |
Depreciation & Amortization | 51.04 | 52.49 | 45.57 | 45.83 | 47.26 | 45.48 |
Other Amortization | 2.1 | 2.1 | 5.33 | 4.2 | 3.13 | 2.14 |
Loss (Gain) From Sale of Assets | -0.51 | -1 | 1.29 | -0.04 | -0.18 | 2.11 |
Asset Writedown & Restructuring Costs | 2.77 | 2.77 | 32.71 | 41.3 | 116 | -20.11 |
Loss (Gain) From Sale of Investments | -1.06 | -1.44 | 0 | -0.17 | -0.3 | -0.06 |
Loss (Gain) on Equity Investments | 0.16 | 0.31 | 0.15 | - | - | - |
Stock-Based Compensation | 0.73 | 1.45 | 4.29 | 0.27 | 3.5 | 5.64 |
Provision & Write-off of Bad Debts | 1.01 | -1 | 2.73 | 10.55 | 17.03 | 10.83 |
Other Operating Activities | 21.39 | 30.41 | 31.61 | 25.63 | 34.16 | 21.9 |
Change in Accounts Receivable | 11.29 | 23.61 | 47.09 | 105.45 | -51.19 | 10.68 |
Change in Inventory | 63.51 | 50.37 | -6.44 | -17.23 | 4.68 | 11.34 |
Change in Accounts Payable | -11.43 | -10.81 | 10.47 | 9.61 | -22.56 | -29.62 |
Change in Unearned Revenue | 0.62 | 0.86 | -0.01 | -2.05 | -3.22 | 2.52 |
Change in Income Taxes | -0.4 | - | 5.84 | -4.17 | - | - |
Change in Other Net Operating Assets | -9.56 | -10.69 | 5.08 | -10.45 | -40.94 | 25.29 |
Operating Cash Flow | 93.1 | 103.99 | 79.61 | 88.51 | -14.52 | 119.85 |
Operating Cash Flow Growth | -4.63% | 30.62% | -10.05% | - | - | -8.65% |
Capital Expenditures | -13.93 | -14.81 | -19.18 | -20.83 | -3.09 | -76.05 |
Sale of Property, Plant & Equipment | 3.48 | 3.48 | - | 0.1 | 2.89 | 0.68 |
Sale (Purchase) of Intangibles | -1.47 | -1.58 | -2.48 | -1.89 | -3.47 | -6.8 |
Investment in Securities | - | - | -0.63 | -1.98 | - | - |
Other Investing Activities | 14.12 | 1.19 | 4.09 | -6.64 | 9.67 | -9.94 |
Investing Cash Flow | 2.19 | -11.71 | -18.2 | -31.25 | 6.01 | -92.11 |
Short-Term Debt Issued | - | 3 | - | 5.55 | 2.16 | - |
Long-Term Debt Issued | - | 200.19 | 253.03 | 342.11 | 374.88 | 407.19 |
Total Debt Issued | 86.36 | 203.19 | 253.03 | 347.66 | 377.05 | 407.19 |
Short-Term Debt Repaid | - | - | -7.71 | - | - | -15 |
Long-Term Debt Repaid | - | -266.38 | -340.29 | -359.87 | -363.89 | -460.68 |
Total Debt Repaid | -157.44 | -266.38 | -348 | -359.87 | -363.89 | -475.68 |
Net Debt Issued (Repaid) | -71.08 | -63.18 | -94.97 | -12.21 | 13.16 | -68.49 |
Issuance of Common Stock | - | - | - | 0.8 | - | 105.31 |
Other Financing Activities | -18.84 | -23.25 | -27.42 | -24.18 | -27.03 | -40.43 |
Financing Cash Flow | -89.91 | -86.43 | -122.39 | -35.59 | -13.87 | -3.61 |
Foreign Exchange Rate Adjustments | -11.41 | -13.18 | 5.28 | -5.51 | 6.25 | 1.25 |
Net Cash Flow | -6.03 | -7.33 | -55.71 | 16.16 | -16.14 | 25.38 |
Free Cash Flow | 79.16 | 89.18 | 60.43 | 67.68 | -17.61 | 43.81 |
Free Cash Flow Growth | -2.26% | 47.58% | -10.72% | - | - | -32.37% |
Free Cash Flow Margin | 22.83% | 23.34% | 14.85% | 15.10% | -2.67% | 7.28% |
Free Cash Flow Per Share | 0.20 | 0.23 | 0.15 | 0.17 | -0.04 | 0.12 |
Cash Interest Paid | 18.84 | 23.25 | 27.42 | 24.18 | 27.03 | 33.17 |
Cash Income Tax Paid | 1.88 | -0.15 | 2.3 | 4.5 | 4.85 | 10.21 |
Levered Free Cash Flow | 46.97 | 65.88 | 83.52 | 82.33 | -36.52 | -40.9 |
Unlevered Free Cash Flow | 59.25 | 80.7 | 100.65 | 97.44 | -19.63 | -24.13 |
Change in Working Capital | 54.03 | 53.33 | 62.02 | 81.17 | -113.24 | 20.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.